Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
36.78
+0.18 (0.49%)
Jan 17, 2025, 4:00 PM EST - Market closed
Bright Minds Biosciences Cash Flow Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Net Income | -2.8 | -2.8 | -7.37 | -14.96 | -8.65 | -0.48 | |
| Depreciation & Amortization | 0.07 | 0.07 | 0.07 | 0.01 | - | - | |
| Asset Writedown & Restructuring Costs | - | - | - | 0 | - | - | |
| Stock-Based Compensation | 0.84 | 0.84 | 1.15 | 0.9 | 0.88 | 0.16 | |
| Other Operating Activities | -0 | -0 | 0.07 | -0.26 | 0.14 | - | |
| Change in Accounts Payable | 0.24 | 0.24 | -1.2 | 0.77 | 0.51 | 0.11 | |
| Change in Other Net Operating Assets | -0.2 | -0.2 | 0.26 | -0.04 | -0.2 | -0.08 | |
| Operating Cash Flow | -1.85 | -1.85 | -7.02 | -13.59 | -7.32 | -0.29 | |
| Long-Term Debt Repaid | -0.09 | -0.09 | -0.09 | -0.01 | - | - | |
| Net Debt Issued (Repaid) | -0.09 | -0.09 | -0.09 | -0.01 | - | - | |
| Issuance of Common Stock | 0.9 | 0.9 | 1.47 | 6 | 27.84 | 1.01 | |
| Other Financing Activities | 0 | 0 | 0.8 | -0.8 | -1.79 | - | |
| Financing Cash Flow | 0.81 | 0.81 | 2.19 | 5.2 | 26.06 | 1.01 | |
| Foreign Exchange Rate Adjustments | 0.01 | 0.01 | -0.05 | 0.26 | 0.22 | - | |
| Net Cash Flow | -1.03 | -1.03 | -4.88 | -8.13 | 18.96 | 0.72 | |
| Free Cash Flow | -1.85 | -1.85 | -7.02 | -13.59 | -7.32 | -0.29 | |
| Free Cash Flow Per Share | -0.43 | -0.43 | -1.89 | -5.50 | -4.08 | -0.40 | |
| Levered Free Cash Flow | -0.69 | -0.69 | -4.22 | -7.58 | -3.85 | -0.1 | |
| Unlevered Free Cash Flow | -0.68 | -0.68 | -4.22 | -7.58 | -3.85 | -0.1 | |
| Change in Net Working Capital | -0.04 | -0.04 | 0.94 | -0.72 | -0.29 | -0.04 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.